The present invention relates to a compound which acts as a selective antagonist of the transient receptor potential cation channel subfamily M member 8 (hereinafter referred to as TRPM8) having the formula (I) , Ischemia, neurodegeneration, stroke, mental disorders, itching, irritable bowel disease, cold-induced and / or aggravated respiratory disorders, and urological disorders: (I) .
展开▼